Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacological therapy for proliferative vitreoretinopathy.

N D Radtke, A D Weinsieder, R J Ballou

    Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie
    |January 1, 1986
    PubMed
    Summary

    Researchers created a rabbit eye model to test a drug that reduces extracellular matrix formation. The study found cis-hydroxyproline decreased traction retinal detachments by 48%.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Preliminary report: indications of improved visual function after retinal sheet transplantation in retinitis pigmentosa patients.

    American journal of ophthalmology·1999
    Same author

    Anterior proliferative vitreoretinopathy in the silicone study. Silicone Study Report Number 10.

    Ophthalmology·1996
    Same author

    Meeting the needs of the 21st century--through programs of awareness and education.

    The Journal of the Kentucky Medical Association·1992
    Same author

    Management of exudative retinal detachment after plaque therapy for intraocular melanoma.

    American journal of ophthalmology·1991
    Same author

    Mitochondrial stability in taurine perfused, hypoxic bovine eye.

    Progress in clinical and biological research·1990
    Same author

    Isolated, perfused bovine eye a model for acute retinal toxicity screening.

    Lens and eye toxicity research·1989

    Area of Science:

    • Ophthalmology
    • Cell Biology
    • Pharmacology

    Background:

    • Extracellular matrix (ECM) overproduction contributes to retinal detachment.
    • Developing effective treatments for traction retinal detachments is crucial.

    Purpose of the Study:

    • To establish a rabbit eye model for testing agents that inhibit ECM formation.
    • To evaluate the efficacy of cis-hydroxyproline in reducing ECM-related complications in the eye.

    Main Methods:

    • An animal model was developed using intravitreal injection of heterotransplanted bovine retinal pigment epithelial cells in rabbit eyes.
    • The pharmacological agent cis-hydroxyproline was administered at doses of 20 and 60 micrograms.
    • The rate of traction retinal detachments was measured as an outcome.

    Related Experiment Videos

    Main Results:

    • Administration of cis-hydroxyproline led to a significant reduction in ECM formation.
    • A 48% decrease in the rate of traction retinal detachments was observed with cis-hydroxyproline treatment.
    • The rabbit eye model proved effective in evaluating the pharmacological agent.

    Conclusions:

    • cis-hydroxyproline demonstrates potential as a therapeutic agent to reduce extracellular matrix formation.
    • This study validates a novel animal model for investigating treatments for retinal detachment.
    • Further research is warranted to explore the clinical applications of cis-hydroxyproline in ophthalmology.